Abstract
Background: We report a case of spinal abscess/osteomyelitis at the T9-T10 levels in a non-immunocompromised patient who presented with lower extremity weakness secondary to a Mycobacterium abscessus infection. This patient was successfully treated with surgical debridement with amikacin-tigecycline-imipenem triple therapy before and after her debridement. Outcomes and treatment with this rare cause of epidural abscess/osteomyelitis are not well defined at this time.
Case Report: Clinical Presentations with this species of mycobacterium are usually systemic with patients presenting with pulmonary and soft tissue infections. The primary presentation of spinal epidural abscess/osteomyelitis is unusual, especially when there is no primary focus such as a lung infection or concurrent bacteremia. Conclusion: This paper presents a new case of spinal osteomyelitis without a primary source in addition to 10 previously reported M. abscessus cases. The treatment plans and outcomes suggest that surgical debridement along with a macrolide-based combination therapy should be considered a definitive treatment against Mycobacterium abscesses.Keywords: Mycobacterium abscessus, osteomyelitis, diagnosis, management, outcomes, epidural abscess.
Graphical Abstract
[PMID: 16725007]
[PMID: 23569523]
[http://dx.doi.org/10.1155/2014/197061] [PMID: 25544922]
[PMID: 11317255]
[PMID: 23925676]
[PMID: 31126264]
[http://dx.doi.org/10.1038/s41394-019-0197-5] [PMID: 31632711]
[PMID: 19171799]
[PMID: 14563223]
[PMID: 29942485]
[PMID: 9502484]